The global urinary catheters market size was estimated at USD 6.17 billion in 2024 and is projected to reach USD 10.93 billion by 2033, growing at a CAGR of 6.6% from 2025 to 2033. Market growth is primarily driven by the rising prevalence of urological disorders, including urinary incontinence (UI), benign prostatic hyperplasia (BPH), and spinal cord injuries (SCI), which often require long-term catheterization to manage urinary functions effectively.

The aging population, coupled with an increasing number of surgical procedures and hospitalizations, further fuels demand for urinary catheters. Additionally, the expanding adoption of home healthcare and the growing preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheters, are accelerating market growth.

Technological advancements also play a significant role in driving market expansion. Innovations like antimicrobial coatings and silicone-based materials improve patient comfort, reduce the risk of infections, and enhance overall safety. Greater awareness among patients and caregivers regarding urinary management options further supports adoption, ensuring that a wider population can access effective solutions for urological conditions.

The increasing burden of urinary disorders is a key factor contributing to the growing demand for urinary catheters. According to NCBI data from August 2024, an estimated 13 million individuals in the U.S. are directly affected by urinary incontinence. In Australia, data from Continence Health Australia (March 2024) indicates that UI affects up to 10% of men and as many as 38% of women. This substantial prevalence is driving increased use of external urinary catheters, which are particularly effective in managing urinary incontinence and improving patient quality of life.

Key Market Trends & Insights:

• North America dominated the global urinary catheters market in 2024, capturing the largest revenue share of 34.97%. The region’s strong market position is driven by advanced healthcare infrastructure, high awareness of urinary disorders, and widespread adoption of innovative catheter technologies.

• Within North America, the U.S. accounted for the largest market revenue share of 82.27% in 2024, reflecting the country’s large patient population, increasing prevalence of urological disorders, and well-established home healthcare and hospital networks that facilitate catheter usage.

• By product, the intermittent catheters segment led the market with the largest revenue share of 57.91% in 2024. Intermittent catheters are preferred due to their ease of use, reduced risk of infections, and suitability for both hospital and home care settings.

• By application, the urinary incontinence segment dominated in 2024, accounting for the largest revenue share of 37.29%. The growing number of patients experiencing urinary incontinence, coupled with increased awareness and availability of external and intermittent catheter solutions, drives demand in this segment.

• By type, the coated catheters segment led the market with the largest revenue share of 61.06% in 2024. Coated catheters are favored for their improved patient comfort, reduced friction, and lower risk of urinary tract infections, making them the preferred choice in both clinical and home care settings.

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 6.17 Billion

• 2033 Projected Market Size: USD 10.93 Billion

• CAGR (2025-2033): 6.6%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The urinary catheters industry is highly fragmented, consisting of both major global players and numerous local competitors. With existing market participants striving to capture a larger share, the industry is expected to experience intense competition, which may increase further as new entrants and established players implement aggressive growth strategies. Many companies are actively pursuing strategic initiatives such as launching new products, undertaking mergers and acquisitions, and expanding into new geographic regions to strengthen their market positions and differentiate themselves from competitors. As a result of these combined strategies, the urinary catheters market is projected to witness steady growth during the forecast period, driven by innovation, expanding applications, and rising demand from both hospital and home healthcare sectors.

Key Players

• BD

• Coloplast Corp

• B.Braun SE

• Medline Industries, LP.

• Hollister Incorporated

• Cook

• Teleflex Incorporated

• Optimum Medical Limited

• Convatec

• Boston Scientific Corporation

• Ur24Technology, Inc.

• Stryker

• InnoCare Urologics

• Boehringer Laboratories, LLC

• Consure Medical

• TillaCare Ltd.

• Medtronic

• Urotronic, Inc. (Laborie)

• Silq Technologies

• Wellspect HealthCare, a Dentsply Sirona Company

• GHC German Health Care GmbH

• Sterimed Group

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global urinary catheters market is expected to experience steady growth, driven by the rising prevalence of urological disorders, an aging population, and increasing surgical procedures and hospitalizations. Demand is further fueled by the growing adoption of home healthcare and minimally invasive urinary management solutions, including intermittent and external catheters. Technological advancements, such as antimicrobial coatings and the use of silicone and hydrophilic materials, are enhancing patient comfort, safety, and compliance.